Pfizer shares rose Tuesday morning after the pharmaceutical company affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.
On Tuesday, Biomea Fusion Inc. (NASDAQ:BMEA) revealed topline results from the ongoing COVALENT-111 study of icovamenib in patients with type 2 diabetes (T2D). Icovamenib was investigated in three different dosing arms with a primary follow-up after 26 weeks: Arm A at 100mg QD (once daily) for 8 weeks, Arm B at 100mg QD for 12 weeks, and Arm C at 100 mg QD for 8 weeks and 100mg BID (twice daily) for 4 weeks. Also Read: FDA Removes Clinical Hold On Biomea Fusion’s Early-Stage Trials For Potential
RLUSD is initially available on exchanges including Uphold, Bitso, MoonPay, Archax, and CoinMENA.
Retail sales increased in November amid a strong start to the holiday shopping season.
(Bloomberg) -- In what’s been a record-breaking year for Bitcoin, the originators of the world’s first exchange-traded funds to hold the cryptocurrency appear to be at risk of being left behind. Most Read from BloombergHow California Sees the World, and ItselfHong Kong's Expat Party Hub Reshaped by Chinese InfluxLondon’s Tube Fares Are Set to Rise by 4.6% Next YearBitcoin ETFs were launched in Canada in February 2021, making them the first in the world. This led to billions of dollars of inflows
Here’s what could be next for SoundHound AI.
Stocks like NVDA, V, HOOD, SHOP and SQ are poised to benefit from Bitcoin's ongoing rally.
EVgo said its largest investor would be selling 23 million shares of Class A common stock, sending them sharply lower Tuesday morning.
Digital asset laws should enshrine decentralization standards, helping to guard against volatility, scams and casino culture, says a16z’s Miles Jennings.
Discovering breakout stocks requires analysis and intuition. Here are seven tips to spot future winners now.
